Navigation Links
Bernstein Liebhard LLP Launches New Transvaginal Mesh Lawsuit Website as Claims Continue to Mount in U.S. Litigations
Date:12/28/2013

(PRWEB) December 28, 2013

A new transvaginal mesh lawsuit (http://www.transvaginalmeshlawsuitclaims.com/) website has been launched by the attorneys at Bernstein Liebhard LLP, who are actively filing claims on behalf of women who may have sustained pelvic mesh injuries.

The Firm’s new site will include vital information regarding the process of filing a case alleging mesh erosion, pain, vaginal scarring, infection, organ perforation and other serious complications, as well as updates in the fast-growing nationwide litigation of vaginal mesh lawsuits. According to court documents, at least 40,000 claims involving this class of devices, which are used in the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), are currently pending in federal and state courts throughout the U.S. These lawsuits involve products marketed by such manufacturers as Ethicon Inc., American Medical Systems, Inc., C.R. Bard, Inc., and Boston Scientific Corp.

“As we continue to speak with women who have allegedly been injured as a result of transvaginal mesh, our Firm recognizes the importance of providing a website that educates women about mesh lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices. In addition to its new website, the Firm is currently offering free and confidential case evaluations to women who may have been injured as a result of pelvic mesh.

Transvaginal Mesh Lawsuits
The majority of transvaginal mesh lawsuits filed in the U.S. are now pending in separate federal multidistrict litigations established in the U.S. District Court, Southern District of West Virginia. These proceedings include: American Medical Systems (MDL No. 2325), Boston Scientific Corp., (MDL No. 2326); C.R. Bard, Inc., (MDL No. 2187), and E
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pradaxa Lawsuits Mount, as Claims in Federal Multidistrict Litigation Exceed 2,000, Bernstein Liebhard LLP Reports
2. Transvaginal Mesh Lawsuits Move Forward, as Federal Litigations Prep for 2014 Bellwether Trials, Bernstein Liebhard LLP Reports
3. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Finding that Acetaminophen Combined With Alcohol May Increase Risk for Kidney Damage
4. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order Pertaining to Discovery in Federal Boston Scientific Litigation
5. GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Joint Motion in Federal GranuFlo Recall Litigation
6. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes Publication of New Study Questioning Cost, Benefits of Robotic Surgery
7. Bernstein Liebhard LLP Notes Progress in Federal Byetta Lawsuit Litigation, Where More than 160 Claims Have Now Been Filed
8. More Than 430 Cases Now Filed in Federal GranuFlo Lawsuit Litigation, Bernstein Liebhard LLP Continues to Investigate Dialysis Claims
9. Bernstein Liebhard LLP Notes Filing of New Mirena Lawsuit Alleging Spontaneous IUD Migration, other Complications
10. Nearly 900 Cases Now Pending in Federal Biomet Hip Lawsuit Litigation; Federal Judge Sets Deadlines for Bellwether Trial Selection, Bernstein Liebhard LLP Reports
11. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes New Da Vinci Robot Recall for Endowrist Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... to treat severe chronic migraine headaches led to significant ... in patients treated at Massachusetts General Hospital (MGH). ... Surgery report that more than half of 35 patients ... had headaches associated with compression of craniofacial nerves ... team,s paper has received advance online publication in the ...
(Date:7/28/2014)... Glutamine is the most abundant single amino ... conditionally essential during times when the body undergoes large ... Immune System Support. , Having a heavy work out ... with additional glutamine may be advantageous. Glutamine supplementation may ... digestion and immune system function. Stress on the body ...
(Date:7/28/2014)... 2014 (HealthDay News) --,The more chronic medical conditions people ... may be, a new study claims. Since ... issues, scientists at Johns Hopkins Bloomberg School of Public ... why gains in life expectancy are slowing in the ... as diabetes, kidney disease and heart failure is now ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 The ... organization that has donated more than 200,000 books to ... 2001, announces the launch of Brooke’s Cooks, a new ... while encouraging healthy living among at-risk children and their ... will include a series of nutrition information workshops, cooking ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Cell's recycling center implicated in division decisions 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
... 3 Endologix, Inc. (Nasdaq: ELGX ), developer of minimally ... and Chief Executive Officer, is scheduled to present at three upcoming ... Adams 3rd Annual Cardiovascular Conference at the Nikko Hotel in San ... Event: Canaccord Adams 3rd Annual Cardiovascular Conference, ...
... after the attacks, study shows , TUESDAY, Nov. 3 (HealthDay ... asthma rates twice that of the general population, a new ... and volunteers who had spent time at Ground Zero reported ... about 4 percent of the general population. The rate of ...
... , TUESDAY, Nov. 3 (HealthDay News) -- Experts have ... healthier than regular cigarettes, and new research suggests they ... less likely to quit, even those who switch specifically ... "switching to [,light, cigarettes] for any reason ...
... NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ... announced it will web cast a conference call to review fiscal ... ), on Monday, November 9, 2009 at 4:30 PM (ET). ... results will be issued at 4:00 PM (ET) that day. , ...
... COLUMBUS, Ohio, Nov. 3 National claims and risk management ... approach to claims management that ensures medical experts are involved ... company notes that the goal of the new service is ... the duration and overall cost of workers, comp claims. Avizent ...
... ... of the Health IT Standards Committee hearing held in Washington, D.C. last week, which was ... ... Orion Health Inc. endorses and commends the efforts of the Health IT Standards Committee ...
Cached Medicine News:Health News:Endologix to Present at Three Upcoming Conferences 2Health News:World Trade Center Workers Twice as Likely to Have Asthma 2Health News:World Trade Center Workers Twice as Likely to Have Asthma 3Health News:Switch to 'Light' Cigarettes Makes Quitting Tougher 2Health News:Switch to 'Light' Cigarettes Makes Quitting Tougher 3Health News:NBTY to Web Cast Fiscal Fourth Quarter Conference Call 2Health News:Avizent's New TeamCOMP Approach Helps Ensure Lower Workers' Comp Costs and Faster Claims Resolution 2Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 2Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 3Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 4
(Date:7/28/2014)... 2014  Array BioPharma Inc. (Nasdaq:   ARRY) ... quarter and full year of fiscal 2014 ... those results on Tuesday, August 12, 2014.  ... Michael Carruthers , Chief Financial Officer will ... 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass Code: ...
(Date:7/28/2014)... July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... announced today that its new PicoWay® device has received ... and colors and pigmented lesions on any skin type. ... with 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary ... pulses which are trillionths of a second, known as ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... April 17, 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc. ... conducted Phase 2 clinical trials,of GVAX immunotherapy ... patients with advanced prostate cancer from these,studies ... responses to a broad array of prostate ...
... A 9-month, randomized,double-blind, parallel-group Phase II study of ... given daily to the currently,approved COPAXONE(R) 20 mg ... disease activity as measured by magnetic,resonance images (MRI) ... mg experienced a reduced mean on-trial relapse rate,of ...
Cached Medicine Technology:Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5
... The StatusFirst CHF test ... anti-NT-proBNP antibody/streptavidin solid-phase chromatographic ... a sample has been ... well, the StatusFirst CHF ...
... practices that need an ... Burdick Vision,Premier Holter System ... The Vision Premier system,adds ... a,more comprehensive list of ...
... EK-10 single-channel,electrocardiograph features a ... keypad. It provides the,necessary ... quick and,accurate diagnosis. The ... a built in handle ...
... contrast levels (high, 9.5 % and 6%) of ... is designed to detect very subtle changes in ... or due to refractive surgery. The upper two ... and acuity levels as the lower two rows; ...
Medicine Products: